共 27 条
- [21] ASSOCIATION OF THE AUTOANTIBODIES TO M-TYPE PHOSPHOLIPASE A2 RECEPTOR TITER WITH CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY-5-YEAR FOLLOW UP STUDYACTA CLINICA CROATICA, 2021, 60 : 71 - 77Laganovic, MarioHorvatic, IvicaBubic, IvanIlic, MarioMaksimovic, BojanaKozmar, AnaBrinar, Ivana VukovicCrnogorac, MatijaZivko, MarijanaFistrek, MargaretaJurekovic, ZeljkaLjubanovic, Danica GalesicCoric, MarijanaBulimbasic, StelaGalesic, KresimirKnotek, Mladen
- [22] Preliminary Study of β1-Adrenergic Receptor and M2 Muscarinic Cholinergic Receptor Mediated Protective Effect of Electroacupuncture on PC6 against Myocardial IschemiaACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH, 2017, 42 (3-4) : 227 - 239Shi, LiZhao, Ji-PingGao, Jun-HongZhang, Jin-LingZhu, BingYu, Xiao-ChunRong, Pei-Jing
- [23] ADVANTAGES OF PHARMACOGENETIC APPROACH (POLYMORPHISMS' OF GENES CYP2C9 AND VKORC1 STUDY) TO WARFARIN DOSING, AGAINST THE STANDARD METHOD FOR RUSSIAN PATIENTS WITH CONSTANT ATRIAL FIBRILLATIONBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 73 - 74Sychev, D.Antonov, IIgnatev, I.Kasakov, R.Gerasimova, K.Dmitriev, VKukes, V
- [24] The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort studyCardiovascular Diabetology, 21Yi-Hsin ChanTze-Fan ChaoShao-Wei ChenHsin-Fu LeePei-Ru LiWei-Min ChenYung-Hsin YehChi-Tai KuoLai-Chu SeeGregory Y. H. Lip
- [25] The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort studyCARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)Chan, Yi-HsinChao, Tze-FanChen, Shao-WeiLee, Hsin-FuLi, Pei-RuChen, Wei-MinYeh, Yung-HsinKuo, Chi-TaiSee, Lai-ChuLip, Gregory Y. H.
- [26] Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong KongCARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)Lui, David Tak WaiTang, Eric Ho ManWu, TingtingAu, Ivan Chi HoLee, Chi HoWoo, Yu ChoTan, Kathryn Choon BengWong, Carlos King Ho
- [27] Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong KongCardiovascular Diabetology, 22David Tak Wai LuiEric Ho Man TangTingting WuIvan Chi Ho AuChi Ho LeeYu Cho WooKathryn Choon Beng TanCarlos King Ho Wong